As the 12th Ministerial Conference of the WTO is underway, there is a big question mark hovering over the TRIPS waiver proposal. Why are developing countries pushing for a TRIPS waiver? Why are the developed countries and Big Pharma stalling it? In this episode, NewscClick editor-in-chief Prabir Purkayastha and Prof. Satyajit Rath, an immunologist and adjunct faculty at IISER, Pune, discuss the need for TRIPS flexibilities as underlined under the Doha Declaration on Public Health and the importance of the TRIPS waiver proposal in the context of COVID-19 mooted by India and South Africa.
Importance of TRIPS flexibilities under the Doha Declaration on Public Health
NewscClick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the TRIPS waiver and the larger question of intellectual property rights and public health
